The effects of cytokine stimulation [recombinant human interleukin (rhlL)-la, rhlL-3, rhlL-6, rhlL-11, and rh granulocytemacrophage colony-stimulating factor (GM-CSF)] on the secretory activity of normal human megakaryocytes were studied by means of the reverse hemolytic plaque assay (RHPA) in enriched cell preparations. This test facilitates an extremely sensitive determination of cytokine secretion at the single-cell level, together with the clear-cut identification of each immunostained (CD611 secretory active megakaryocyte. Moreover, the reverse transcriptase-polymerase chain reaction (RT-PCR) was used t o investigate the expression of IL-6, IL-6 receptor (IL-6R). IL-9, IL-IO, IL-12, and IL-13 mRNA in highly concentrated megakaryocyte preparations. In comparison with the spontaneous secretion rate, stimulation with rhlL-la, rhlL-6, and rhGM-CSF failed t o induce a significant increase in the release of cytokines by CD61+ cells. On UMAN MEGAKARYOPOIESIS is generally regarded as a complex phenomenon that includes proliferation of committed progenitor cells, cellular maturation with associated nuclear polyploidization (endoreduplication) and growth in size, and platelet prod~ction."~ These complicated processes are at least in part regulated by certain interleukins (ILs) and colony-stimulating factors (CSFS)!"~ Several recently published studies20321 have provided strong evidence for the suggestion that a hypersensitivity orland a reduced responsiveness to several cytokines may explain the proliferation of this cell lineage in myeloproliferative disorders (MPDs).
The effects of cytokine stimulation [recombinant human interleukin (rhlL)-la, rhlL-3, rhlL-6, rhlL-11, and rh granulocytemacrophage colony-stimulating factor (GM-CSF)] on the secretory activity of normal human megakaryocytes were studied by means of the reverse hemolytic plaque assay (RHPA) in enriched cell preparations. This test facilitates an extremely sensitive determination of cytokine secretion at the single-cell level, together with the clear-cut identification of each immunostained (CD611 secretory active megakaryocyte. Moreover, the reverse transcriptase-polymerase chain reaction (RT-PCR) was used t o investigate the expression of IL-6, IL-6 receptor (IL-6R). IL-9, IL-IO, IL-12, and IL-13 mRNA in highly concentrated megakaryocyte preparations. In comparison with the spontaneous secretion rate, stimulation with rhlL-la, rhlL-6, and rhGM-CSF failed t o induce a significant increase in the release of cytokines by CD61+ cells. On UMAN MEGAKARYOPOIESIS is generally regarded as a complex phenomenon that includes proliferation of committed progenitor cells, cellular maturation with associated nuclear polyploidization (endoreduplication) and growth in size, and platelet prod~ction."~ These complicated processes are at least in part regulated by certain interleukins (ILs) and colony-stimulating factors (CSFS)!"~ Several recently published studies20321 have provided strong evidence for the suggestion that a hypersensitivity orland a reduced responsiveness to several cytokines may explain the proliferation of this cell lineage in myeloproliferative disorders (MPDs).
Additionally, pathologic release of certain cytokines probably takes part in the pathogenesis of the myelofibrosi~~~-~~ frequently accompanying MPDs. This hypothesis has especially stimulated a renewed interest in the study of megakaryopoiesis in both normal and disordered states of the bone However, the megakaryopoietic lineage represents only a small fraction of the nucleated cells within the human bone marrow. Hence, attempts to clarify the role of this peculiar cell type within the hematopoietic microenvironment meet certain technical difficulties. Failure to determine the secretory activity of megakaryocytes may be due to the fact that these mediators are acting at very low concentrations?'
The present study was undertaken to assess cytokine release, ie, the secretion of IL-la, IL-3, IL-6, and granulocytemacrophage (GM)-CSF by normal human megakaryocytes. For this purpose, we applied the reverse hemolytic plaque assay (RHPA) because of its high sensitivity and the possibility of identifying single actively secreting cell elements by immunohistochemical Further experiments using the reverse transcriptase-polymerase chain reaction (RT-PCR) technique for the detection of IL-6, IL-6 receptor (IL-6R), IL-9, IL-10, IL-12, and IL-13 mRNA were performed using highly purified megakaryocyte preparations.
H

MATERIALS AND METHODS
Marrow cell preparation. Bone marrow specimens were obtained from the sternum of 50 patients undergoing thoracotomy for Blood, Vol 85, No 3 (February I), 1995: pp 685-691 the other hand, both rhlL-3 and, in a less pronounced way, rhlL-l1 exerted a marked effect on IL-6 secretion. Additionally, after stimulation with rhlL-3, a significant enhancement of the secretion of IL-3 and GM-CSF, but not of IL-la, could be observed. Using the RT-PCR, a significant induction of IL-6 expression could be appreciated in the enriched megakaryocyte population (60% t o 80%) stimulated with rhlL-3. The results of this study provide persuasive evidence that a number of cytokines are synthesized and secreted by human megakaryocytes and not only by hematopoietic stroma cells. These data suggest the existence of autocrine and paracrine mechanisms that may influence maturation and differentiation of megakaryocytes as well as act on various stroma cells t o sustain an appropriate hematopoietic microenvironment. 0 1995 by The American Society of Hematology. various surgical procedures. These patients presented without hematologic disorders and with platelet counts within the normal range. Informed consent was obtained from all donors. Marrow particles were immediately transferred to serum-free Iscove's medium (GIBCO, Paisley, UK) containing penicillin (100 U/mL), streptomycin (100 pg/mL; Biochrom, Berlin, Germany), and 0.1% bovine serum albumin (BSA) purchased from Sigma (St Louis, MO). Medullary cells were isolated from bone particles in 30-mm culture dishes (Greiner, Frickenhausen, Germany) after gentle agitation for 4 hours at 37°C in a humidified atmosphere of 5% COz in air.
Megakaryocyte purz$cation procedure. Megakaryocytes were enriched by density centrifugation at 400g over a single-density Percoll gradient (density, 1.050 g/mL; Seromed, Berlin, Germany) and washed twice in Iscove's medium containing penicillin, streptomycin, and 0.1% BSA. The interphase was collected, and cells were resuspended to a final concentration of 2 X lo6 to 3 X lo6 cells per milliliter in RPM1 1640 supplemented with 0.1% BSA, penicillin (100 U/mL), and streptomycin (100 pg/mL). Before the RT-PCR procedure, Percoll interphase cells were first incubated with CD61 antibody (Y2/51, 10 pg/mL; Dako, Hamburg, Germany) for IO minutes on ice and subsequently stained with anti-IgG1-MACS beads (1:5 dilution; Miltenyi Biotec, Bergisch-Gladbach, Germany) for 5 minutes at room temperature. Finally, the cells were separated over a miniMACS column (Miltenyi Sequences of the oligonucleotide primers used for RT-PCR to determine cytokine gene expression in the current study and the expected lengths of the amplification products are listed. Primer sequences for 0-actin and IL-6 have been described previou~ly.~' Primer design was facilitated by extensive European Molecular Biology Laboratory (EMBL) and GenBank database searches using the VAX-computer at the Department of Genetics, University of Cologne, as well as the Experimental GENINFO BLAST Network Service at the National Center for Biotechnology Information (NCBI), Bethesda, MD.54 fractions were diluted to lo5 cells per milliliter in RPMI 1640 medium supplemented with 0.1% BSA and penicillin/streptomycin and incubated at 37°C in a humid atmosphere with 5% CO,. Samples were stimulated by addition of 5 ng/mL recombinant human (rh) IL-la, 5 ng/mL rhIL-3, or 5 ng/mL rhIL-6, respectively, over a period of 8 hours. The megakaryocyte mRNA was isolated according to a protocol described p r e v i o~s l y .~~ Briefly, megakaryocytes were collected by centrifugation, and then the cell pellets were lysed in 200 pL of a solution containing 4 m o m guanidinium isothiocyanate, 25 mmol/L sodium citrate, 0.1 molL 2-mercaptoethanol, and 0.5% N-laurylsarcosine and were vortexed vigorously. After extraction with water-saturated phenol, chloroform, and ch1oroform:isoamyl alcohol (49:l voUvol), cellular mRNA was precipitated by adding 70% ice-cold ethanol and subsequently washed with isopropyl alcohol. The mRNA obtained was vacuum-dried and dissolved in diethyl pyrocarbonate (DEPC)-treated water to a final volume of 20 pL. Reverse transcription was performed in a total volume of 20 pL using oligo (dT),, (Promega, SERVA Feinbiochemica, Heidelberg, Germany) as primer and the reverse transcriptase Superscript 11, according to the instructions of the manufacturer (GIBCO-BRL, Eggenstein, Germany). After reverse transcription, 3 pL of the reaction solution was used for PCR amplification with the primers listed in Table 1 . Using a hot start technique35 combined with a "touch down" temperature prot~col,'~ 40 cycles were performed on a thermocycler (Perkin Elmer, Duesseldorf, Germany) using a sample volume of 50 pL. A second round of 40 PCR cycles was performed using 10 pL of the amplified material and fresh Taq-polymerase. The products were separated on 5% NuSieve agarose gels (Biozym Diagnostic, Hessisch Oldendorf, Germany) containing ethidium bromide and photographed.
Human hematopoietic cytvkines. Specific activity (sp act) of cytokines was as follows: (1) rhIL-la: sp act greater than 2 X 10' Ulmg protein determined by the antiproliferative effects on A375 indicator cells (Genzyme, Boston, MA); (2) rhL-3: sp act greater than 2 X lo7 U/mg protein determined by the proliferative effect on TF-1 responder cells (Genzyme); (3) rhIL-6: sp act greater than IO' U/mg protein determined by the amount required to induce proliferation of B9 hybridoma cells in vitro (Genzyme); (1) rhIL-11: sp act greater than 2 X 10' U/mg protein determined by that amount required to induce half-maximum proliferation of TI 165 murine hybridoma cells (Genzyme); and (5) rhGM-CSF: sp act greater than 1.25 X IO' U/mg protein determined by a proliferation assay measuring TF-1 cell incorporation of 'H-TdR in a 96-hour microassay (Genzyme).
Human hematopoietic cytvkine-neutralizing antisera and antibodies. Antisera and antibodies were as follows: (1) rabbit polyclonal antiserum to human IL-la, 90% IgG: 1.0 mg of antibody neutralizes 1,000 U of rhIL-la, as determined by the phytohemagglutinin-induced thymocyte proliferation assay (Genzyme); (2) rabbit polyclonal antiserum to human IL-3: 5 pg neutralizes 1,000 U rhIL-3; (3) rabbit polyclonal antiserum to human IL-6, 80% IgG: I O to 50 pL/mL of antibody is recommended for the precipitation of rhIL-6; and (4) rabbit polyclonal antiserum to human GM-CSF, 80% IgG: 1 . O pg of antiserum neutralizes 20.0 ng of human GM-CSF as determined by radioimmunoassay based on anti-GM-CSF/GM-CSF binding (Genzyme). The polyclonal antisera were able to bind to Staphylococcus protein A, as could be shown in a modified protein dot blot test using protein A gold (Biotrend, Cologne, Germany).
Test conditions. Cells were either used for the RHPA immediately or incubated in rolling plastic flasks for 8 hours in the presence of the above-mentioned mediators (IO ng/mL rhIL-la, 10 pg/mL rhGM-CSF, 5 ng/mL rhIL-3, IO ng/mL rhIL-6, and 10 ng/mL rhIL-11) in megakaryocyte medium.37
RHPA. We used the RHPA according to modifications described previo~sly.'~~'~ Principles of this method are schematically shown in Fig 1. Briefly, freshly prepared stimulated or unstimulated human bone marrow cells were mixed with an equal volume of sheep red blood cells (SRBC) coupled to protein A (Sigma). Sheep leukocytes had been removed before conjugation procedure using a Percoll gradient method. The cell mixture was aliquoted into poly-L-lysinecoated Cunningham chambers and allowed to settle onto the glass slides for 60 minutes at 37°C in a humidified atmosphere of 5% CO2 in air. To obtain a confluent layer of cells attached to the glass floor of the chamber, the excess of unattached cells was removed by rinsing each chamber with prewarmed RPMI 1640 medium containing 0.1% BSA, penicillin (100 U/mL), and streptomycin (100 pg/mL). The chambers were then filled with test solutions of 1/200 (vol/vol) dilutions of one of the above-mentioned polyclonal rabbit antisera, and slides were incubated at 37°C for 6 hours. Afterwards, chambers were washed with medium to remove any unbound antibody or secretory product, and chambers were filled with a dilution of 1/50 guinea pig complement (GIBCO) to initiate plaque formation by hemolysis (Figs 1 and 2A and B) . After 30 minutes cells were exposed to 0.5% (vol/vol) glutaraldehyde in TRIS-buffered saline (TBS) for 3 minutes. After this fixation step, cover slips were removed from the chambers, and the slides were rinsed in TBS and prepared for immunolabeling.
Identification of megakaryocytes. Megakaryocytes were identified by immunostaining with a monoclonal antibody (MoAb) directed against platelet glycoprotein IIIa (Y2/51, CD61)40 according to the ABC method (Fig 2A and B) .4' The MoAb was purchased from Dako.
Quantitative analysis. Data are presented as means -t SEM. Statistical analysis of the data was performed by the Mann-Whitney U test. In a pilot study a statistical analysis of variance between the different donors has been performed to assure reliability of data. However, no significant differences could be calculated, and for this reason, pooled data are presented.
Controls. Megakaryocyte viability was checked by the fluorescein diacetate method (Sig~na).~'.~~ Cells were incubated with the CD61 for 10 minutes at 0°C. Subsequently, the cells were washed and then incubated with a 1:20 dilution of rhodamine-conjugated goat F(ab')z antimouse IgG (Tago Inc. Burlingame, CA) and a fluorescein diacetate solution (0.1 pglmL) for 20 minutes at 0°C. After washing, the cells were examined with a Zeiss Photoscope 3 (Carl Zeiss. Oberkochen, Germany) for both fluorescein and rhodamine fluorescence. The data presented are given in relation to the viable megakaryocyte population. In control experiments, the specificity of plaque formation was determined for the secretion of the examined cytokines by different means: plaque formation was not found if ( I ) human marrow cells were discarded, and the assay was performed using SRBC alone; (2) the specific antibodies were replaced by normal rabbit serum; (3) complement was omitted; or (4) SRBC not coated by protein A were used.
RESULTS
After centrifugation over a single-density Percoll gradient, the megakaryocyte fraction showed an average purity small (A) and medium-sized (B) megakaryocytes at the center of a . . . of the nonviable cells increased to up to 30% after stimulation with the growth factors, irrespective of plaque formation.
The effects of stimulation (8 hours) by rhIL-3 (5 ng/mL) and rhIL-1 1 (1 0 ng/mL) on the secretory activity (IL-1 a , IL-3, IL-6, and GM-CSF) of human megakaryocytes are shown in Figs 2A and B and 3A in comparison with the basal (spontaneous) activity. Data concerning stimulation with other cytokines, ie, rhIL-la (10 ng/mL), rhIL-6 (l0 ng/mL), or rhGM-CSF (10 pg/mL), are summarized in Fig 3B. In all samples under study, cytokine release could be clearly determined by the ability of the immunostained megakaryocytes to form distinctive hemolytic zones in the plaque assay.
Spontaneous secretion of the tested growth substances by megakaryocytes in serum-free medium was low and ranged between 0.8 (IL-6) and 4.7 (GM-CSF) plaque-forming cells per 1,000 megakaryocytes (Fig 3A) . After incubation for 8 hours before performing the RHPA, rhIL-3 and rhIL-11-but not rhIL-la, rhIL-6, or rhGM-CSF-were capable of inducing a significant ( P < .05) increase in the release of IL-6 in relation to the spontaneous secretion of this cytokine. In addition, stimulation with rhIL-3 was found to significantly ( P < .05) enhance IL-3 (48.4 plaque-forming cells per 1,000 megakaryocytes) and GM-CSF secretion (59.6 plaqueforming cells per 1,000 megakaryocytes). After the observa-WICKENHAUSER ET AL tion of a stimulatory activity of rhIL-3 on human megakaryocytes in the RHPA, additional experiments using the RT-PCR were performed. This technique enabled us to investigate the behavior of cytokines in the absence of commercially available antibodies and to confirm that active synthesis was taking place by the cells under study. As shown in Fig 4, stimulation of a highly enriched megakaryocyte fraction with rhIL-3 for 8 hours markedly induced the expression of IL-6 mRNA, whereas no change in the expression of IL-6R, IL-9, IL-IO, IL-12, and IL-13 mRNA could be observed. Treatment with IL-la and IL-6 did not induce an expression of the examined cytokines. In control experiments with native bone marrow cell preparations, IL-6 mRNA expression could only be shown after stimulation with rhIL-1 and also rhIL-6.
With our test conditions, significant differences ( P < .05) in the IL-6 and GM-CSF secretion of the megakaryocytes could be detected between the different stimulation protocols, especially concerning the influence of cytokines with overlapping activity spectrum (IL-6 and IL-11). It became apparent that the most actively secreting megakaryopoietic cells consisted predominantly of small, more immature elements (pro-and megakaryoblasts), although some release of cytokines was also measurable in the larger (polyploid) megakaryocytes.
DISCUSSION
As megakaryocytes belong to the most fragile cell population within the bone marrow, all enrichment procedures are prone to damage their morphology and alter their function. The problematic purification of megakaryocytes is bypassed by using the RHPA. This immunologic technique was originally developed by Jeme et alZ9 and modified by Molinaro and Dray3" to detect antigen formation of individual cells. This technique is ideally suited for the investigation of cytokine secretion in heterogeneous cell populations, as cytokine release is shown at the single-cell level. After detection of cytokine-secreting cells, immunocytochemistry with lineage-specific MoAbs is performed, and only immunoidentified cells are evaluated. Thus, we were able to evaluate the cytokine production by CD61' human megakaryocytes in enriched and unpurified cell preparations. With this method, it was possible to examine at the single-cell level the secretory activity of immunoidentified human megakaryocytes and the effects of several cytokines (rhlL-la, rhIL-3, rhIL-6, rhIL-11, and rhGM-CSF) on their secretory pattern. In contrast with the more commonly used reverse enzymelinked immunospot (RELISPOT) techniq~e:".'~ this method facilitates the clear-cut identification of each secretory active cell. According to our findings, the spontaneous secretion of the above-mentioned cytokines by CD61' cells was low. This observation is in agreement with that of other investigat o r~~~ who did not detect larger amounts of secreted L 6 by murine hematopoietic progenitors of the bone marrow. In comparison with the spontaneous secretion rate, rhIL-la, rhIL-6, and rhGM-CSF did not induce a significant enhancement of cytokine release by megakaryocytes. On the other hand, optimal concentrations of both rhL-3 and. in a less distinctive way, rhL-l1 exerted significant effects on IL-6 secretion. In addition, a significant increase in the release of IL-3 and GM-CSF, but not IL-1 a, could be appreciated after stimulation with rhL-3. For the first time, our results prove the release of IL-la, IL-3, IL-6, and GM-CSF by single normal human megakaryocytes. Perhaps the most compelling evidence supporting the assumption of an endogenous cytokine production was that the RT-PCR showed measurable amounts of IL-6 mRNA only after stimulation of a highly enriched megakaryocyte population with rhIL-3. In control experiments on unpurified bone marrow cell preparations, we tested the influence of rhlLla and rhIL-6 on cytokine expression. As the induction of IL-6 mRNA by rhIL-3 stimulation was only observed in the enriched megakaryocyte fraction and not in unpurified bone marrow cells, other contaminating cell lineages could be excluded as the source of IL-6. On the other hand, IL-6 mRNA could be shown after treatment of the control cell population with IL-la. Using the RT-PCR, we did not show an expression of a battery of cytokines (IL-9, IL-IO, IL-12, IL-13, and IL-6R). We were not able to examine the secretion of these cytokines, because no polyclonal antibodies were available commercially at the time of our studies. This is in contrast with the findings of a former study." However, test conditions differed considerably because those investigators examined megakaryocytes previously cultured for at least 6 days in serum-containing medium. Also, the enrichment procedure was not as effective as in our study, so that other contaminating cell lineages cannot be ruled out as the source of this cytokine.
Many in vivo and in vitro investigations have clearly established the influence of several cytokines on proliferation and maturation of human megakaryopoietic progenit~rs.~"' The most effective cytokine to support megakaryocyte proliferation and also differentiation is known to be I L _~,~-I O . I~. I~. I " -I X although there is some evidence that this cytokine is not very effective in promoting endoreduplication.I4 IL-I 1 and IL-6 were reported to display a wide spectrum of biologic activities. Similar to IL-6,JK IL-l1 acts synergistically with IL-3 to shorten the Go period of the cell cycle, particularly in early progenitor However, the effect of GM-CSF on megakaryocyte progenitors continues Although there may be no doubt about the involvement of several cytokines in the regulation of human megakaryopoiesis, the active role of this cell lineage concerning the to be cOntrOVerSia~~4. 7 
